Merck Vs JNJ, Merck’s Got More Magic

Johnson & Johnson’s stock has gained 38% since the March 23 lows of this year, while Merck’s stock has slightly underperformed and gained 30% of its value. The lockdown in various parts of the world has had a negative impact on the pharmaceuticals industry worldwide due to deferment of elective…

About the Author

has written 23418 stories on this site.

Copyright © 2010 corporatecommunicationsnews101.com